Literature DB >> 15116332

Vasculogenic mimicry has no prognostic significance in pT3 and pT4 cutaneous melanoma.

Daniela Massi1, Alessandro Franchi, Milena Paglierani, Sheyda Ketabchi, Lorenzo Borgognoni, Umberto Maria Reali, Marco Santucci.   

Abstract

The concept of vasculogenic mimicry has been introduced to define periodic acid-Schiff (PAS)-positive channels and loops lined by tumor cells, instead of endothelium, able to contribute to microcirculation in uveal melanomas. Previous studies have shown that the PAS-positive patterns are associated with a poor prognosis in uveal melanoma. The aim of the current study was to investigate whether vasculogenic mimicry has a prognostic impact in pT3 and pT4 cutaneous melanoma. Fifteen patients with pT3 and pT4 cutaneous melanoma who did not experience progression after 10 years of follow-up and 30 matched controls who underwent progression were selected. Tumor sections were stained with PAS reaction, omitting the nuclear counterstaining. For immunohistochemistry, sections were stained with CD31, CD105 (endoglin), and laminin. Differences in the distribution of the PAS-positive patterns and a series of clinicopathological variables were evaluated by the Pearson chi(2) and Mann-Whitney U tests. We observed PAS-positive linear sheets, arcs, elliptical loops, and networks encircling roundish to oval aggregates of melanoma cells. The overall distribution of the PAS-positive patterns did not match with the blood microvessels' architecture as detected by immunohistochemical analysis. No statistically significant differences in the distribution of PAS-positive patterns were found between cases and controls. The presence of a parallel pattern correlated significantly with thickness (P = 0.04), whereas an inverse correlation was found with vessel area (P = 0.05). In conclusion, our results suggest that there is a mismatch between vasculogenic mimicry and tumor angiogenesis and do not support any prognostic role of vasculogenic mimicry in thick cutaneous melanoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15116332     DOI: 10.1016/j.humpath.2003.10.022

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  11 in total

1.  Prognostic significance and mechanisms of patterned matrix vasculogenic mimicry in hepatocellular carcinoma.

Authors:  Wen-bin Liu; Ge-liang Xu; Wei-dong Jia; Jian-sheng Li; Jin-liang Ma; Ke Chen; Zhi-hua Wang; Yong-sheng Ge; Wei-hua Ren; Ji-hai Yu; Wei Wang; Xiu-Jun Wang
Journal:  Med Oncol       Date:  2010-10-19       Impact factor: 3.064

2.  Endoglin (CD105) as a prognostic factor in head and neck squamous cell carcinoma.

Authors:  Panayiotis A Kyzas; Niki J Agnantis; Dimitrios Stefanou
Journal:  Virchows Arch       Date:  2006-04-13       Impact factor: 4.064

3.  CD105 expression as a measure of microvessel density in supraglottic laryngeal squamous cell carcinoma.

Authors:  Elvir Zvrko; Anton Mikic; Ljiljana Vuckovic
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-04-02       Impact factor: 2.503

4.  A pilot study of vasculogenic mimicry immunohistochemical expression in hepatocellular carcinoma.

Authors:  Grace Guzman; Scott J Cotler; Amy Y Lin; Andrew J Maniotis; Robert Folberg
Journal:  Arch Pathol Lab Med       Date:  2007-12       Impact factor: 5.534

5.  Clinical significance of vasculogenic mimicry in human gliomas.

Authors:  Xiao-mei Liu; Qing-ping Zhang; Yong-gao Mu; Xiang-hen Zhang; Ke Sai; Jesse Chung-Sean Pang; Ho-Keung Ng; Zhong-ping Chen
Journal:  J Neurooncol       Date:  2011-04-30       Impact factor: 4.130

6.  Prognostic significance of melanoma differentiation and trans-differentiation.

Authors:  Nityanand Maddodi; Vijayasaradhi Setaluri
Journal:  Cancers (Basel)       Date:  2010-05-26       Impact factor: 6.639

Review 7.  Advanced research on vasculogenic mimicry in cancer.

Authors:  Lili Qiao; Ning Liang; Jiandong Zhang; Jian Xie; Fengjun Liu; Deguo Xu; Xinshuang Yu; Yuan Tian
Journal:  J Cell Mol Med       Date:  2015-01-19       Impact factor: 5.310

Review 8.  Overview of advances in vasculogenic mimicry - a potential target for tumor therapy.

Authors:  Hong Ge; Hui Luo
Journal:  Cancer Manag Res       Date:  2018-08-02       Impact factor: 3.989

9.  Vasculogenic Mimicry: A Promising Prognosticator in Head and Neck Squamous Cell Carcinoma and Esophageal Cancer? A Systematic Review and Meta-Analysis.

Authors:  Roosa Hujanen; Rabeia Almahmoudi; Sini Karinen; Bright I Nwaru; Tuula Salo; Abdelhakim Salem
Journal:  Cells       Date:  2020-02-24       Impact factor: 6.600

10.  The role of vascular mimicry as a biomarker in malignant melanoma: a systematic review and meta-analysis.

Authors:  Zhenhua Zhang; Saber Imani; Marzieh Dehghan Shasaltaneh; Hossein Hosseinifard; Linglin Zou; Yu Fan; Qinglian Wen
Journal:  BMC Cancer       Date:  2019-11-21       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.